Condition
Severe Community-acquired Pneumonia (sCAP)
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting3
Terminated1
Enrolling By Invitation1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07301099Not Yet RecruitingPrimary
Epidemiology and Current Practices in Severe Community-Acquired Pneumonia
NCT07152587Phase 2Not Yet RecruitingPrimary
Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)
NCT07070284Enrolling By InvitationPrimary
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"
NCT06977347Not ApplicableNot Yet RecruitingPrimary
Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
NCT04280354Terminated
Molecular Biomarkers for Sepsis
Showing all 5 trials